MAIA Biotechnology, Inc. Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

6 Months Ended

Jun. 30, 2024

3. ACCRUED EXPENSES

As of June 30, 2024 and December 31, 2023 accrued expenses consisted of the following:


	June 30,		December 31,
	2024		2023
Bonus	$	448,443	$	786,999
Professional fees		85,621		77,942
Research and development costs		991,260		998,838
Accrued severance		404,834		824,435
Other		317,129		610,393
Total accrued expenses	$	2,247,287	$	3,298,607